Tarr T - Search Results

1

A comprehensive investigation on the distribution of circulating follicular T helper cells and B cell subsets in primary Sjögren's syndrome and systemic lupus erythematosus.

Szabó K, Papp G, Szántó A, Tarr T, Zeher M. Szabó K, et al. Among authors: tarr t. Clin Exp Immunol. 2016 Jan;183(1):76-89. doi: 10.1111/cei.12703. Epub 2015 Oct 21. Clin Exp Immunol. 2016. PMID: 26358223 Free PMC article.

2

[Lipid profile in patients with systemic lupus erythematosus, with special focus on lipoprotein(a) in lupus nephritis].

Kiss E, Fazekas B, Tarr T, Muszbek L, Zeher M, Szegedi G. Kiss E, et al. Among authors: tarr t. Orv Hetil. 2004 Feb 1;145(5):217-22. Orv Hetil. 2004. PMID: 15024932 Hungarian.

3

[Is the primary antiphospholipid syndrome a forerunner of SLE?].

Tarr T, Muzes G, Pitlik E, Lakos G, Csépány T, Soltész P, Zeher M, Szegedi G, Kiss E. Tarr T, et al. Orv Hetil. 2005 Jan 30;146(5):203-7. Orv Hetil. 2005. PMID: 15773587 Review. Hungarian.

4

[Clinical experiences with cyclosporin A in patients with systemic lupus erythematosus].

Tarr T, Zeher M, Szegedi G, Kiss E. Tarr T, et al. Orv Hetil. 2005 Dec 4;146(49):2485-9. Orv Hetil. 2005. PMID: 16398313 Hungarian.

5

[The occurrence of malignancies in a Hungarian lupus population].

Tarr T, Szekanecz E, Zeher M, Szegedi G, Kiss E. Tarr T, et al. Orv Hetil. 2006 Nov 19;147(46):2229-33. Orv Hetil. 2006. PMID: 17396395 Hungarian.

6

Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus.

Tarr T, Lakos G, Bhattoa HP, Szegedi G, Shoenfeld Y, Kiss E. Tarr T, et al. Lupus. 2007;16(5):324-8. doi: 10.1177/0961203307077993. Lupus. 2007. PMID: 17576733

7

Measurement of natural (CD4+CD25high) and inducible (CD4+IL-10+) regulatory T cells in patients with systemic lupus erythematosus.

Barath S, Aleksza M, Tarr T, Sipka S, Szegedi G, Kiss E. Barath S, et al. Among authors: tarr t. Lupus. 2007;16(7):489-96. doi: 10.1177/0961203307080226. Lupus. 2007. PMID: 17670847

8

Occurrence of malignancies in Hungarian patients with systemic lupus erythematosus: results from a single center.

Tarr T, Gyorfy B, Szekanecz E, Bhattoa HP, Zeher M, Szegedi G, Kiss E. Tarr T, et al. Ann N Y Acad Sci. 2007 Jun;1108:76-82. doi: 10.1196/annals.1422.008. Ann N Y Acad Sci. 2007. PMID: 17893972

9

Reduced paraoxonase1 activity is a risk for atherosclerosis in patients with systemic lupus erythematosus.

Kiss E, Seres I, Tarr T, Kocsis Z, Szegedi G, Paragh G. Kiss E, et al. Among authors: tarr t. Ann N Y Acad Sci. 2007 Jun;1108:83-91. doi: 10.1196/annals.1422.009. Ann N Y Acad Sci. 2007. PMID: 17893973

10

Clinical thrombotic manifestations in SLE patients with and without antiphospholipid antibodies: a 5-year follow-up.

Tarr T, Lakos G, Bhattoa HP, Soltesz P, Shoenfeld Y, Szegedi G, Kiss E. Tarr T, et al. Clin Rev Allergy Immunol. 2007 Apr;32(2):131-7. doi: 10.1007/s12016-007-0009-8. Clin Rev Allergy Immunol. 2007. PMID: 17916982

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81 results

Search Page

Filters